首页> 美国卫生研究院文献>Heliyon >The experimental research on neuroplasticity in rats’ hippocampus subjected to chronic cerebral hypoperfusion and interfered by Modified Dioscorea Pills
【2h】

The experimental research on neuroplasticity in rats’ hippocampus subjected to chronic cerebral hypoperfusion and interfered by Modified Dioscorea Pills

机译:改良地黄丸干预慢性脑灌注不足大鼠海马神经可塑性的实验研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic Cerebral Hypoperfusion (CCH) is a common, crucial and tough problem for old people. It easily leads to Lacunar Infarction and even Vascular Dementia (VD). Western medicine has the advantage to relieve some VD symptoms but fails to cure it. Some classic Chinese medicines have good efficacies to treat and delay the cerebral functional decline resulted from CCH. Among them Modified Dioscorea Pills (MDP) has been proven to have a convincing effect in curing VD. So far the knowledge about neuroplasticity in CCH is little known and the underlying interfered mechanism by MDP on neuroplasticity has not yet been explored. This study explores the changes of neuroplasticity involving neurogenesis, angiogenesis and synaptogenesis in CCH and interfered by MDP.
机译:慢性脑灌注不足(CCH)对于老年人来说是一个常见,关键且棘手的问题。它很容易导致腔隙性梗塞,甚至导致血管性痴呆(VD)。西药具有缓解某些VD症状的优势,但无法治愈。一些经典中药具有很好的疗效,可以延缓CCH引起的脑功能衰退。其中,改性薯os丸(MDP)已被证明在治疗VD中具有令人信服的作用。到目前为止,关于CCH中神经可塑性的知识鲜为人知,并且尚未探索MDP对神经可塑性的潜在干扰机制。这项研究探讨了神经可塑性的变化,涉及CCH中神经发生,血管生成和突触的发生,并受到MDP的干扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号